AstraZeneca and the University of Oxford got the go-ahead to restart their US coronavirus vaccine trials.<br />The late-stage trial was stopped due to a possible adverse reaction in one of the participants.<br />On September 6 AstraZeneca reported a "suspected serious adverse reaction".<br />According to Business Insider, the reaction occurred in a UK-based participant.<br />The UK resumed clinical trials for AstraZeneca and the University of Oxford vaccines in September.<br />The trials in Japan resumed earlier this month.
